2. Search Result
Search Result
Results for "

A1C

" in MedChemExpress (MCE) Product Catalog:

5

Inhibitors & Agonists

3

Peptides

4

Recombinant Proteins

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-106181
    Rivoglitazone

    R-106056

    		 PPAR Cardiovascular Disease Metabolic Disease
    Rivoglitazone (R-106056) is an orally active, selective PPARγ agonist with an EC50 of 0.22 μM for hPPARγ. Rivoglitazone regulates fatty acid storage and uptake, glucose homeostasis, and cardiac glucose/fatty acid metabolism. Rivoglitazone reduces levels of hyperglycemia, hyperinsulinemia, and hypertriglyceridemia, decreases hepatic glucose production, and accelerates plasma triglyceride clearance. Rivoglitazone induces a reduction in glycated hemoglobin A1C, while causing peripheral edema and weight gain. Rivoglitazone can be used in research related to type 2 diabetes [1] .
    Rivoglitazone
  • HY-108795
    Albiglutide fragment

    GLP-1-Gly8; GLP-1 (7-36) analog

    		 GLP Receptor Metabolic Disease
    Albiglutide fragment (GLP-1 (7-36) analog) is an active fragment of Albiglutide (7-36) and a glucagon-like peptide-1 (GLP-1) analog (a long-acting GLP-1 receptor agonist). Albiglutide is produced by the fusion of DPP-4 resistant GLP-1 dimer with the human albumin gene. Moreover, Albiglutide fragment significantly reduces glycosylated hemoglobin (A1C) and is used in type 2 diabetes (T2D) studies [1] .
    Albiglutide fragment
  • HY-E70082
    Fructosyl amino acid oxidase

    		Biochemical Assay Reagents Metabolic Disease
    Fructosyl amino acid oxidase can be used to measure glycosylated protein. Glycosylated protein, especially glycosylated hemoglobin A1c, is an important marker to evaluate the efficacy of diabetes treatment [1].
    Fructosyl amino acid oxidase
  • HY-108795A
    Albiglutide fragment TFA

    GLP-1-Gly8 TFA; GLP-1 (7-36) analog TFA

    		 GLP Receptor Metabolic Disease
    Albiglutide fragment (GLP-1 (7-36) analog) TFA is an active fragment of Albiglutide (7-36) and a glucagon-like peptide-1 (GLP-1) analog (a long-acting GLP-1 receptor agonist). Albiglutide is produced by the fusion of DPP-4 resistant GLP-1 dimer with the human albumin gene. Moreover, Albiglutide fragment TFA significantly reduces glycosylated hemoglobin (A1C) and is used in type 2 diabetes (T2D) studies [1] .
    Albiglutide fragment TFA
  • HY-108795R
    Albiglutide fragment (Standard)

    GLP-1-Gly8 (Standard); GLP-1 (7-36) analog (Standard)

    		 Reference Standards GLP Receptor Metabolic Disease
    Albiglutide fragment (Standard) is the analytical standard of Albiglutide fragment (HY-108795). This product is intended for research and analytical applications. Albiglutide fragment (GLP-1 (7-36) analog) is an active fragment of Albiglutide (7-36) and a glucagon-like peptide-1 (GLP-1) analog (a long-acting GLP-1 receptor agonist). Albiglutide is produced by the fusion of DPP-4 resistant GLP-1 dimer with the human albumin gene. Moreover, Albiglutide fragment significantly reduces glycosylated hemoglobin (A1C) and is used in type 2 diabetes (T2D) studies [1] .
    Albiglutide fragment (Standard)

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

  

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

  

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: